|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| C12Q 1/60 | |||
| A61P 9/10 | |||
| C07K 14/705 | |||
| G01N 33/92 | |||
| G01N 33/50 |
| (11) | Patento numeris | 3292144 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16790128.9 |
| Europos patento paraiškos padavimo data | 2016-05-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/031109 |
| Data | 2016-05-06 |
| (87) | Numeris | WO 2016/179456 |
| Data | 2016-11-10 |
| (30) | Numeris | Data | Šalis |
| 201562158157 P | 2015-05-07 | US |
| (72) |
LIU, Yang, US
ZHENG, Pan, US
|
| (73) |
OncoImmune, Inc.,
9430 Key West Ave., Suite 113, Rockville, MD 20850,
US
|
| (54) | USE OF CD24 FOR LOWERING LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS |
| USE OF CD24 FOR LOWERING LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS |